3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....
3BBLACKBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
3B BlackBio Dx Ltd (formerly Kilpest India Limited) has informed BSE that a meeting of its Board of Directors is scheduled for Friday, 6th February 2026 at 3:00 p.m. at its registered office in Bhopal. The board will consider and approve the Unaudited Standalone and Consolidated Financial Results of the company for the quarter and nine months ended 31st December 2025 (Q3 FY26 results). The trading window for trading in the company's equity shares was closed from 1st January 2026 and will reopen 48 hours after the results are announced on 6th February 2026, in compliance with insider trading regulations.
This is a routine advance notice ahead of the company's Q3 FY26 earnings release. No financial numbers are disclosed in this filing; investors should wait for the actual results on 6th February 2026 for any actionable data. The closed trading window means insiders cannot trade until 48 hours post-results.